Home/Filings/4/0001127602-25-013412
4//SEC Filing

Aguilar Moses Victor Javier 4

Accession 0001127602-25-013412

CIK 0000080424other

Filed

May 5, 8:00 PM ET

Accepted

May 6, 9:43 AM ET

Size

12.7 KB

Accession

0001127602-25-013412

Insider Transaction Report

Form 4
Period: 2025-05-05
Aguilar Moses Victor Javier
Chf Rsch, Dev & Innov Officer
Transactions
  • Exercise/Conversion

    Stock Option (Right to Buy)

    2025-05-0510,5200 total
    Exercise: $80.29From: 2019-02-28Exp: 2026-02-27Common Stock (10,520 underlying)
  • Sale

    Common Stock

    2025-05-05$158.67/sh10,520$1,669,20025,181.569 total
  • Exercise/Conversion

    Common Stock

    2025-05-05$80.29/sh+10,520$844,65135,701.569 total
  • Award

    Restricted Stock Units

    2025-02-18+11.67685.058 total
    Common Stock (11.676 underlying)
Holdings
  • Common Stock

    (indirect: By Trust)
    6,259.851
  • Common Stock

    (indirect: By Trust)
    428.603
Footnotes (5)
  • [F1]Total includes grant of dividend equivalents in the form of Restricted Stock Units (RSU's) settled in common stock and shares acquired through the issuer's dividend reinvestment plan.
  • [F2]Weighted average price of the shares sold. The price range was $158.65 to $158.74. Full information regarding the number of shares sold at each separate price available upon request.
  • [F3]Reflects adjustment to PST through March 31, 2025.
  • [F4]Dividend equivalents in the form of Restricted Stock Units (RSUs) previously awarded pursuant to issuer's retirement program. All such RSUs represent a contingent right to receive Procter & Gamble common stock.
  • [F5]These units will deliver in shares on retirement from the company, unless delivery is deferred or such shares are contributed to reporting person's deferred compensation account.

Issuer

PROCTER & GAMBLE Co

CIK 0000080424

Entity typeother

Related Parties

1
  • filerCIK 0001825382

Filing Metadata

Form type
4
Filed
May 5, 8:00 PM ET
Accepted
May 6, 9:43 AM ET
Size
12.7 KB